Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Marc Gitzinger
Daniel Ritz
Jonathan James Butcher
Nawaz Khan
Anca Cighi
Fiona Gao
Hernan Levett
Philipp Schmid
Board:
David Hunstad
Henni-Karoliina Ropponen
Marina von Schönau
Simona Skerjanec
Ulrik Schulze
Seng Chin Mah
Shareholding in %:
AMR Action Fund GP LLC 2.98
Barrus AG 2.99
Candriam Belgium SA 3.75
GSK Plc 4.34
Marc Gitzinger 1.97
Marc Jaquet 3.13
Marina von Schönau 3.56
Seng Chin Mah 1.31
UBS Asset Management Switzerland AG 5.66
Viavalor AG 3.42
Freefloat 66.9
Address: Hochbergerstrasse 60c, 4057 Basel
T: +41-61-551-51-20
F: +
I: http://www.bioversys.com
E: info@bioversys.com